1. 713PAnalysis of BRCAness with MLPA in pancreatic ductal adenocarcinoma patients using FFPE sample obtained via EUS-FNAB. (23rd October 2018) Authors: Okuwaki, K; Imaizumi, H; Masutani, H; Yoshida, T; Kida, M; Iwai, T; Yamauchi, H; Kaneko, T; Hasegawa, R; Miyata, E; Adachi, K; Tadehara, M; Koizumi, W Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 721PA phase I study of IRISOX (irinotecan/S-1/oxaliplatin) in the second-line treatment for gemcitabine-refractory pancreatic cancer. (23rd October 2018) Authors: Miyata, E; Okuwaki, K; Imaizumi, H; Kida, M; Iwai, T; Yamauchi, H; Kaneko, T; Hasegawa, R; Adachi, K; Tadehara, M; Koizumi, W Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗